background
longitudin
data
chang
hematolog
hepat
renal
function
find
patient
middl
east
respiratori
syndrom
coronaviru
merscov
infect
method
retrospect
cohort
studi
merscov
patient
describ
hematolog
hepat
renal
find
patient
merscov
result
day
observ
signific
chang
hepat
panel
creatinin
test
signific
increas
mean
ae
sd
white
blood
cell
count
ae
ae
p
valu
increas
mean
ae
sd
absolut
neutrophil
count
ae
ae
p
valu
leukocytosi
observ
patient
day
day
transient
leukopenia
develop
patient
day
day
none
patient
neutropenia
lymphopenia
promin
featur
rate
patient
day
day
lymphocytosi
featur
merscov
infect
thrombocytopenia
develop
patient
day
day
thrombocytosi
promin
featur
observ
patient
day
day
conclus
patient
merscov
infect
show
variabl
hematolog
paramet
time
lymphocytosi
neutropenia
featur
merscov
infect
middl
east
respiratori
syndrom
coronaviru
merscov
infect
first
report
saudi
arabia
world
health
organ
report
juli
total
case
includ
death
countri
worldwid
merscov
infect
associ
high
case
fatal
rate
cfr
subsequ
cfr
decreas
patient
milder
form
diseas
although
mani
studi
evalu
clinic
characterist
merscov
patient
none
address
tempor
chang
hematolog
hepat
creatinin
valu
acut
renal
injuri
describ
critic
ill
patient
howev
mani
mer
patient
preexist
chronic
renal
diseas
studi
evalu
tempor
progress
chang
hematolog
hepat
renal
function
cohort
patient
day
hospit
studi
analyz
hematolog
hepat
creatinin
chang
time
cohort
admit
patient
merscov
infect
patient
test
posit
merscov
use
realtim
polymeras
chain
reaction
rtpcr
day
one
first
day
admiss
subsequ
day
admiss
base
calcul
laboratori
data
collect
day
admiss
time
limit
determin
base
fact
patient
discharg
deceas
defin
time
interv
definit
leukopenia
leukocyt
count
cellsl
lymphopenia
lymphocyt
count
cellsl
thrombocytopenia
platelet
count
cellsl
elev
aspart
aminotransferas
ast
alanin
aminotransferas
alt
level
defin
twice
upper
refer
limit
ul
respect
elev
lactat
dehydrogenas
ldh
consid
valu
significantli
elev
upper
normal
level
ul
purpos
studi
collect
daili
laboratori
data
calcul
mean
ae
standard
deviat
sd
given
paramet
also
calcul
number
percentag
patient
abnorm
laboratori
data
defin
studi
approv
institut
review
board
irb
john
hopkin
aramco
healthcar
kendallmann
test
obtain
use
spss
spss
window
version
spss
inc
chicago
il
usa
time
trend
individu
patient
test
monoton
trend
differ
laboratori
variabl
compar
mean
laboratori
valu
patient
time
use
pair
ttest
analysi
varianc
anova
test
use
spss
spss
window
version
spss
inc
test
signific
result
consid
present
p
valu
serum
creatinin
individu
patient
show
signific
trend
time
use
kendallmann
test
except
three
patient
baselin
mean
serum
creatinin
ae
sd
ae
mgdl
indic
presenc
renal
impair
prior
admiss
patient
tabl
howev
mean
serum
creatinin
patient
chang
time
hepat
function
test
result
individu
patient
show
signific
trend
time
use
kendallmann
test
mean
ae
sd
alkalin
phosphatas
ae
ul
ast
ae
ul
ldh
ae
ul
signific
chang
mean
hepat
function
test
patient
studi
period
tabl
howev
increas
test
day
due
singl
patient
develop
shock
liver
day
observ
three
patient
signific
increas
white
blood
cell
wbc
count
use
kendallmann
test
p
signific
increas
mean
ae
sd
wbc
count
ae
ae
cellsl
p
valu
figur
leukocytosi
observ
patient
day
day
transient
leukopenia
develop
patient
day
day
none
patient
leukopenia
day
tabl
signific
increas
mean
ae
sd
absolut
neutrophil
count
ae
ae
cellsl
p
valu
figur
five
patient
signific
correl
trend
absolut
neutrophil
count
time
p
valu
kendallmann
test
cours
observ
neutrophilia
observ
patient
day
day
none
patient
neutropenia
hospit
mean
ae
sd
absolut
lymphocyt
count
show
signific
chang
time
entir
group
patient
p
figur
three
patient
signific
correl
trend
lymphocyt
count
time
p
valu
kendallmann
test
studi
period
lymphopenia
promin
featur
rate
patient
day
day
lymphocytosi
featur
merscov
infect
tabl
mean
ae
sd
platelet
count
show
signific
chang
time
whole
group
patient
p
figur
nine
patient
signific
correl
trend
platelet
count
time
p
valu
kendallmann
test
thrombocytopenia
develop
patient
day
day
thrombocytosi
promin
featur
observ
patient
day
day
studi
evalu
longitudin
trend
laboratori
paramet
patient
merscov
infect
acut
kidney
injuri
one
complic
preexist
condit
merscov
infect
initi
describ
hospit
outbreak
occur
hemodialysi
unit
among
patient
chronic
renal
failur
similarli
major
patient
cohort
preexist
renal
insuffici
cohort
intens
care
unit
icu
patient
renal
replac
therapi
initi
patient
compar
sever
acut
respiratori
syndrom
sar
patient
acut
renal
injuri
may
caus
directli
merscov
summar
case
renal
epitheli
cell
like
produc
infecti
merscov
progeni
bronchial
epitheli
cell
howev
merscov
detect
infrequ
urin
lymphopenia
promin
featur
rate
lymphocytosi
featur
merscov
infect
state
patient
merscov
infect
typic
lymphopenia
icu
patient
merscov
infect
nine
patient
lymphopenia
day
icu
stay
one
studi
case
lymphopenia
initi
featur
compar
lymphocytosi
howev
lymphopenia
featur
diseas
compar
merscov
patient
without
mer
previous
report
lymphocyt
count
rang
follow
rang
rang
rang
report
merscov
case
normal
neutrophil
count
admiss
current
studi
show
normal
neutrophil
count
signific
increas
mean
aesd
count
time
casecontrol
studi
differ
neutrophil
count
mer
case
patient
commun
acquir
respiratori
infect
current
studi
transient
leukopenia
develop
patient
day
observ
patient
leukocytosi
day
increas
wbc
count
time
probabl
reflect
develop
sepsi
superimpos
bacteri
infect
thrombocytopenia
develop
patient
day
patient
day
thrombocytosi
promin
featur
current
studi
variabl
degre
thrombocytopenia
inconsist
report
previou
studi
critic
ill
icu
merscov
patient
thrombocytopenia
note
two
patient
day
seven
patient
icu
stay
first
report
hospit
outbreak
alhasa
four
patient
low
platelet
count
l
l
one
patient
high
platelet
count
l
studi
merscov
case
thrombocytopenia
develop
initi
case
thrombocytopenia
nonspecif
find
mani
viral
infect
sar
sar
case
thrombocytopenia
develop
initi
follow
reactiv
thrombocytosi
reactiv
thrombocytosi
seen
patient
current
studi
elev
level
ldh
ast
alt
found
patient
merscov
observ
signific
trend
time
hepat
panel
gener
elev
ldh
first
day
observ
signific
increas
time
comparison
patient
sar
show
elev
ldh
case
elev
ldh
could
marker
sever
pneumonia
associ
death
patient
legionella
pneumophilia
ldh
also
surrog
marker
steroid
therapi
pediatr
mycoplasma
pneumonia
pneumonia
predictor
refractori
pneumonia
pneumonia
knowledg
ldh
examin
systemat
admit
patient
merscov
infect
although
merscov
patient
elev
ldh
vs
caus
pneumonia
differ
statist
differ
util
marker
predict
merscov
pneumonia
progress
therapi
requir
studi
conclus
merscov
infect
associ
variabl
hematolog
paramet
time
includ
signific
leukocytosi
neutrophilia
lymphocytosi
neutropenia
common
featur
merscov
infect
util
ldh
marker
predict
merscov
pneumonia
progress
therapi
requir
studi
none
author
receiv
fund
contribut
